Fig. 4
From: PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus
Correlation between serum PGLYRP2 and lipid metabolism indexes in SLE patients. (A) SLEDAI was positively correlated with LDL-c (r = 0.47, P < 0.01), Apo-B (r = 0.4524, P < 0.01), and Apo B/A1(r = 0.4015, P < 0.01) in SLE patients. (B) Serum PGLYRP2 was negatively correlated with HDL-c (r = 0.3746, P < 0.05) and Apo-A1 (r = 0.4523, P < 0.01), but positively correlated with Apo-B/A1 (r = 0.3.74, P < 0.05) in SLE patients